TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
37.10
-1.60 (-4.13%)
May 28, 2026, 11:09 AM HKT

HKG:2617 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22
15,63845,604---
Enterprise Value
15,09544,908---
Last Close Price
38.70114.90---
PB Ratio
33.7598.42---
P/TBV Ratio
33.7898.52---
Debt / Equity Ratio
0.000.000.010.010.00
Net Debt / Equity Ratio
-1.17-1.17-1.08-1.06-0.90
Net Debt / EBITDA Ratio
1.631.631.972.203.21
Net Debt / FCF Ratio
1.921.922.092.584.11
Asset Turnover
---0.00-
Quick Ratio
3.803.805.568.1810.15
Current Ratio
3.873.875.668.2411.98
Return on Equity (ROE)
-62.88%-62.88%-41.98%-36.63%-
Return on Assets (ROA)
-32.06%-32.06%-24.05%-23.02%-
Return on Capital Employed (ROCE)
-72.40%-72.40%-55.40%-48.80%-28.60%
Earnings Yield
-2.11%-0.72%---
FCF Yield
-1.81%-0.62%---
Buyback Yield / Dilution
-2.11%-2.11%-0.06%-5.83%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.